BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17158494)

  • 1. The VADO approach in psychiatric rehabilitation: a randomized controlled trial.
    Gigantesco A; Vittorielli M; Pioli R; Falloon IR; Rossi G; Morosini P
    Psychiatr Serv; 2006 Dec; 57(12):1778-83. PubMed ID: 17158494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome assessment of the VADO approach in psychiatric rehabilitation: a partially randomised multicentric trial.
    Pioli R; Vittorielli M; Gigantesco A; Rossi G; Basso L; Caprioli C; Buizza C; Corradi A; Mirabella F; Morosini P; Falloon IR
    Clin Pract Epidemiol Ment Health; 2006 Apr; 2():5. PubMed ID: 16584543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of the "VADO" approach in psychiatric rehabilitation: a controlled study].
    Vittorielli M; Pioli R; Brambilla L; Archiati L; Rossi G; Sleijpen C; Magliano L; Veltro F; Morosini P
    Epidemiol Psichiatr Soc; 2003; 12(1):43-52. PubMed ID: 12723391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient functioning and family burden in a controlled, real-world trial of family psychoeducation for schizophrenia.
    Magliano L; Fiorillo A; Malangone C; De Rosa C; Maj M
    Psychiatr Serv; 2006 Dec; 57(12):1784-91. PubMed ID: 17158495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline personality functioning correlates with 6 month outcome in schizophrenia.
    Fassino S; Pierò A; Mongelli E; Caviglia ML; Delsedime N; Busso F; Gramaglia C; Abbate Daga G; Leombruni P; Ferrero A
    Eur Psychiatry; 2003 May; 18(3):93-100. PubMed ID: 12763293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia.
    Nasrallah H; Morosini P; Gagnon DD
    Psychiatry Res; 2008 Nov; 161(2):213-24. PubMed ID: 18848731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program.
    Prouteau A; Verdoux H; Briand C; Lesage A; Lalonde P; Nicole L; Reinharz D; Stip E
    Schizophr Res; 2005 Sep; 77(2-3):343-53. PubMed ID: 16085207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
    Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
    Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 3-year psychiatric daycare treatment in patients with schizophrenia.
    Inadomi H; Tanaka G; Watanabe S; Nagatomi Y; Mitarai K; Ohsawa R; Kusumeki K; Shimatani T; Hatanaka K; Hiroike T; Teramoto K; Utsunomiya H; Etoh R; Ohta Y
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):246-52. PubMed ID: 15896216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of an adapted Illness Management and Recovery program for people with schizophrenia awaiting discharge from a psychiatric hospital.
    Lin EC; Chan CH; Shao WC; Lin MF; Shiau S; Mueser KT; Huang SC; Wang HS
    Psychiatr Rehabil J; 2013 Dec; 36(4):243-9. PubMed ID: 24320832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.
    Ciudad A; Olivares JM; Bousoño M; Gómez JC; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1515-22. PubMed ID: 16820255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of social skills training and social milieu treatment on symptoms of schizophrenia.
    Dobson DJ; McDougall G; Busheikin J; Aldous J
    Psychiatr Serv; 1995 Apr; 46(4):376-80. PubMed ID: 7788460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.
    Färdig R; Lewander T; Melin L; Folke F; Fredriksson A
    Psychiatr Serv; 2011 Jun; 62(6):606-12. PubMed ID: 21632728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
    Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
    Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Taiwanese Mandarin version of the Personal and Social Performance scale in a sample of 655 stable schizophrenic patients.
    Wu BJ; Lin CH; Tseng HF; Liu WM; Chen WC; Huang LS; Sun HJ; Chiang SK; Lee SM
    Schizophr Res; 2013 May; 146(1-3):34-9. PubMed ID: 23478156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the Personal and Social Performance scale in patients with schizophrenia.
    Nafees B; van Hanswijck de Jonge P; Stull D; Pascoe K; Price M; Clarke A; Turkington D
    Schizophr Res; 2012 Sep; 140(1-3):71-6. PubMed ID: 22749622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.